This study tests a combination of two drugs (vorbipiprant and balstilimab) in people with advanced colorectal or other gastrointestinal cancers that have not responded to prior treatments. The goal is to see if the combination is safe and can shrink tumors or stop them from growi…
Phase: PHASE1, PHASE2 • Sponsor: Rottapharm Biotech • Aim: Disease control
Last updated May 15, 2026 11:57 UTC